Last $5.97 HKD
Change Today -0.04 / -0.67%
Volume 1.8M
As of 2:27 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

citic 21cn co ltd (241) Snapshot

Open
$6.02
Previous Close
$6.01
Day High
$6.04
Day Low
$5.95
52 Week High
03/7/14 - $8.30
52 Week Low
09/18/13 - $0.39
Market Cap
48.8B
Average Volume 10 Days
4.1M
EPS TTM
$-0.0017
Shares Outstanding
8.2B
EX-Date
01/21/98
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CITIC 21CN CO LTD (241)

Related News

No related news articles were found.

citic 21cn co ltd (241) Related Businessweek News

No Related Businessweek News Found

citic 21cn co ltd (241) Details

CITIC 21CN Company Limited, an investment holding company, provides integrated information and content services in the People's Republic of China. It operates through Product Identification, Authentication, and Tracking System (PIATS) Business; and System Integration and Software Development segments. The company offers product tracking, recall, and enforcement information services to relevant authorities through the operation of PIATS; product tracking and logistics information services to manufacturers; and services to consumers for verifying product information and origins. Its PIATS is used for various products, such as drugs, food and beverage, cosmetics, and agricultural resources. The company also provides telecommunications/information value-added services (VAS) comprising SMS, IVRS, and other telecom services; call center outsourcing service for telecom operators, financial institutions, and e-commerce companies; and other telecommunication/information VAS include IP phone service and business SMS services, as well as offers governmental, commercial, and entertainment information through its SMS and IVRS services. CITIC 21CN Company Limited is based in Central, Hong Kong.

citic 21cn co ltd (241) Top Compensated Officers

Chairman of The Board, Chief Executive Office...
Total Annual Compensation: --
Executive Vice Chairman
Total Annual Compensation: $1.3M
Compensation as of Fiscal Year 2014.

citic 21cn co ltd (241) Key Developments

CITIC 21CN Company Limited, Annual General Meeting, Aug 15, 2014

CITIC 21CN Company Limited, Annual General Meeting, Aug 15, 2014., at 10:30 China Standard Time. Location: at Training Theatre, Level 3. Agenda: To receive, consider and adopt the audited consolidated financial statements of the company and its subsidiaries and the reports of the directors and auditors for the year ended March 31, 2014; to re-elect directors; to appoint Ernst & Young as the auditor of the company and to authorize the board of directors of the company to fix their remuneration; to authorize general mandate to the directors to issue and allot share; to grant a general mandate to the directors to repurchase shares; to approve the addition of the aggregate amount of shares repurchased as mentioned in ordinary resolution no. 5 to the aggregate amount that may be issued and allotted pursuant to ordinary resolution no. 4; and to approve the change of the company's name from CITIC 21CN Company Limited to Alibaba Health Information Technology Limited and the adoption and registration of a Chinese name as the secondary name.

CITIC 21CN Company Limited Reports Audited Consolidated Cash Flows Results for the Year Ended March 31, 2014

CITIC 21CN Company Limited reported audited consolidated cash flows results for the year ended March 31, 2014. For the year, the company reported net cash from operating activities of HKD 1,617,000 against net cash used in operating activities of HKD 10,336,000 for the same period last year. Purchase of property, plant and equipment was HKD 4,735,000 against HKD 7,351,000 for the same period last year. Turnover of the Group for the year substantially increased by 279.0% from the restated turnover of HKD 15,889,000 to HKD 60,215,000. The increase was mainly due to the increase in joining fee income received from medical and health institutions following the intensive promotion of PIATS in drug industry and the increased adoption of PIATS by drug manufacturers, drug distributors and pharmaceutical stores and other drug retailers in China.

CITIC 21CN Company Limited Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2014

CITIC 21CN Company Limited reported audited consolidated earnings results for the year ended March 31, 2014. For the year, the company reported turnover of HKD 60,215,000 compared with HKD 15,889,000 for the same period last year. Loss before taxation was HKD 895,000 compared with HKD 41,148,000 for the same period last year. Loss for the year attributable to owners of the company was HKD 6,472,000 or 0.17 Hong Kong cents basic and diluted per share compared with HKD 41,344,000 or 1.11 Hong Kong cents basic and diluted per share for the same period last year. The decrease in loss was due to the net result of various factors including the increase in turnover of PIATS from the drug industry which led to an improved gross profit margin, the increase in gain in other income, gains and losses and the increase in share of profit of an associate as partly offset by the increase in administrative expenses and increase in share of loss of a joint venture.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
241:HK $5.97 HKD -0.04

241 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Pakistan Telecommunication Co Ltd 24.60 PKR +0.44
VimpelCom Ltd $8.62 USD +0.03
View Industry Companies
 

Industry Analysis

241

Industry Average

Valuation 241 Industry Range
No financial data is available for 241.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CITIC 21CN CO LTD, please visit www.citic21cn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.